Fueled by innovation and rising chronic diseases, organoids and spheroids in Asia Pacific revolutionize personalized medicine, regenerative therapies, and ethical drug testing, with China, India, and Japan spearheading cutting-edge research and applications.New Delhi, Dec. 23, 2024 (GLOBE NEWSWIRE) — According to the latest study from Astute Analytica research, the Asia Pacific organoids and spheroids market is projected to hit the valuation of US$ 1,444.49 million by 2033 from US$ 246.66 milliRead More